Close

Tag: Pharmaceuticals

Trump To Roll-Out 340B Drugs Discount Program in 2026

The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals...

Sino Biological Sets New Industry Standard with ProPureâ„¢ Endotoxin-Free Proteins Made in the USA

Sino Biological US, Inc. proudly unveils ProPureâ„¢, an industry-leading line of ultra-pure, endotoxin-free recombinant proteins, fully produced in the USA at its state-of-the-art Center...

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment...

End-To-End Solutions in Pharma Logistics Creating Difference

There is no shred of doubt that every stage of the pharmaceutical supply chain happens to be critical if the life-saving drugs are to...

Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology.  CAMBRIDGE, UK, 08 July 2025 – Optibrium,...

Pharmaceutical Stewardship in LMICs for AMR Control

Pharmaceutical Stewardship in LMICs: Key to Sustainable AMR Control Antimicrobial resistance (AMR) is one of the most challenging health issues of the 21st century, with...

Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices

Dual-active material science solution is ideal for sensitive formulations Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read